Literature DB >> 15120854

Neonatal manipulations of oxytocin alter expression of oxytocin and vasopressin immunoreactive cells in the paraventricular nucleus of the hypothalamus in a gender-specific manner.

Y Yamamoto1, B S Cushing, K M Kramer, P D Epperson, G E Hoffman, C S Carter.   

Abstract

Early postnatal manipulations of oxytocin have long-term behavioral and physiological consequences; the present study examined the hypothesis that oxytocin or its absence influences the subsequent expression of either oxytocin or arginine vasopressin in the CNS. On postnatal day 1 female and male prairie voles (Microtus ochrogaster) received a single i.p. injection of oxytocin (3 microg), oxytocin antagonist (0.3 microg), or 50 microl of isotonic saline or were only handled. On postnatal days 1, 8 and 21, brains were fixed, sectioned and stained for oxytocin or vasopressin immunoreactivity and analyzed as a function of age, treatment and sex. Both oxytocin and vasopressin immunoreactivity were observed on day 1 in the supraoptic and paraventricular nuclei (PVN) of the hypothalamus. Numbers of oxytocin and vasopressin neurons increased with age in both nuclei. Females treated on postnatal day 1 with oxytocin or oxytocin antagonist displayed a significant increase in oxytocin immunoreactivity on day 21 in the PVN. In contrast, males treated with antagonist tended to have decreased vasopressin immunoreactivity in the same region. These results revealed that the effects of neonatal manipulation of oxytocin are age-dependent, site-specific and sexually dimorphic. The long-lasting effects of neonatal exposure to exogenous oxytocin and oxytocin antagonist indicate a role for oxytocin in the development of the CNS during the neonatal period, affecting the development of the oxytocinergic system in females and the vasopressinergic system in males. The developmental effects observed suggest one possible mechanism by which neonatal exposure to oxytocin or neonatal inhibition of endogenous oxytocin produces long-lasting behavioral and physiological alterations and could play a role in the development of male- and female-typical behavior.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15120854     DOI: 10.1016/j.neuroscience.2004.02.028

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  52 in total

1.  Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems.

Authors:  J P Stohn; M E Martinez; M Zafer; D López-Espíndola; L M Keyes; A Hernandez
Journal:  Genes Brain Behav       Date:  2017-08-04       Impact factor: 3.449

2.  Early life manipulations of vasopressin-family peptides alter vocal learning.

Authors:  Nicole M Baran; Samantha C Peck; Tabitha H Kim; Michael H Goldstein; Elizabeth Adkins-Regan
Journal:  Proc Biol Sci       Date:  2017-07-26       Impact factor: 5.349

Review 3.  Oxytocin Modulation of Neural Circuits.

Authors:  Mariela Mitre; Jessica Minder; Egzona X Morina; Moses V Chao; Robert C Froemke
Journal:  Curr Top Behav Neurosci       Date:  2018

4.  Neonatal oxytocin and vasopressin manipulation alter social behavior during the juvenile period in Mongolian gerbils.

Authors:  Jack H Taylor; Jon Cavanaugh; Jeffrey A French
Journal:  Dev Psychobiol       Date:  2017-05-31       Impact factor: 3.038

5.  Effects of Chronic Oxytocin Administration and Diet Composition on Oxytocin and Vasopressin 1a Receptor Binding in the Rat Brain.

Authors:  Sara M Freeman; Julie Ngo; Bhavdeep Singh; Megan Masnaghetti; Karen L Bales; James E Blevins
Journal:  Neuroscience       Date:  2018-07-31       Impact factor: 3.590

6.  Modulation of cardiac oxytocin receptor and estrogen receptor alpha mRNAs expression following neonatal oxytocin treatment.

Authors:  Hossein Pournajafi-Nazarloo; Eros Papademeteriou; Leila Partoo; Habibollah Saadat; Bruce S Cushing
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

7.  Borderline personality disorder: current drug treatments and future prospects.

Authors:  Bayanne Olabi; Jeremy Hall
Journal:  Ther Adv Chronic Dis       Date:  2010-03       Impact factor: 5.091

Review 8.  The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.

Authors:  Barbara Stanley; Larry J Siever
Journal:  Am J Psychiatry       Date:  2009-12-01       Impact factor: 18.112

9.  Oxytocin and vasopressin modulation of social anxiety following adolescent intermittent ethanol exposure.

Authors:  Carol A Dannenhoffer; Esther U Kim; Jessica Saalfield; David F Werner; Elena I Varlinskaya; Linda P Spear
Journal:  Psychopharmacology (Berl)       Date:  2018-08-23       Impact factor: 4.530

Review 10.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.